LISTSERV mailing list manager LISTSERV 16.0

Help for PARKINSN Archives


PARKINSN Archives

PARKINSN Archives


PARKINSN@LISTSERV.UTORONTO.CA


View:

Message:

[

First

|

Previous

|

Next

|

Last

]

By Topic:

[

First

|

Previous

|

Next

|

Last

]

By Author:

[

First

|

Previous

|

Next

|

Last

]

Font:

Proportional Font

LISTSERV Archives

LISTSERV Archives

PARKINSN Home

PARKINSN Home

PARKINSN  December 1997, Week 3

PARKINSN December 1997, Week 3

Subject:

Aspartame and depression

From:

"Kathrynne Holden, MS,RD" <[log in to unmask]>

Reply-To:

Parkinson's Information Exchange <[log in to unmask]>

Date:

Sat, 20 Dec 1997 12:50:21 -0700

Content-Type:

text/plain

Parts/Attachments:

Parts/Attachments

text/plain (53 lines)

Dear listfriends,
Aspartame has been on my mind for quite some time, and I've been seeking
references that might indicate adverse reactions are possible for some
people. Thanks to a professional listserve and some diligent work on the
part of other concerned RDs, a study has indeed surfaced. Although a
single study is rarely conclusive, I believe that the results of this
study warrant further research, and that PWP would be well advised to
discontinue use of aspartame, at least if they experience mood
disorders.

For those interested, here it is:


Walton RG, Hudak R, Green-Waite RJ.  Department of Psychiatry,
Northeastern
Ohio Universities College of Medicine, Youngstown.
Adverse reactions to aspartame:  double-blind challenge in patients from
a vulnerable population.
 Biol Psychiatry 1993 Jul 1-15; 34(1-2):13-7.

This study was designed to ascertain whether individuals with mood
disorders
are particularly vulnerable to adverse effects of aspartame.  Although
the
protocol required the recruitment of 40 patients with unipolar
depression and
a similar number of individuals without a psychiatric history, the
project
was halted by the Institutional Rview Board after a total of 13
individuals
had completed the study because of the severity of reactions within the
group
of patients with a history of depression.  In a crossover design,
subjects
received aspartame 30 mg/kg/day or placebo 7 days.  Despite the small n,

there was a significant difference between aspartame and placebo in
number
and severity of symptoms for patients with a history of depression,
whereas
for individuals without such a history there was not.  We conclude that
individuals with mood disorders are particularly sensitive to this
artificial
sweetener and its use in this population should be discouraged.




--
Kathrynne Holden, MS, RD
"Nutrition you can live with!"
Medical nutrition therapy
Tel: 970-493-6532 // Fax: 970-493-6538

Top of Message | Previous Page | Permalink

Advanced Options


Options

Error during command authentication.

Error - unable to initiate communication with LISTSERV (errno=111). The server is probably not started.

Log In

Log In

Get Password

Get Password


Subscribe or Unsubscribe

Subscribe or Unsubscribe


Archives

ATOM RSS1 RSS2



LISTSERV.UTORONTO.CA

CataList Email List Search Powered by the LISTSERV Email List Manager